Kodiak Sciences KOD
NASDAQ KOD
$35.36 -1.00 (-2.75%)
As of: Sep 4, 2026 · 3:59 PM EDT

Kodiak Sciences (KOD) Interest & Investment Income (2018 - 2026)

Kodiak Sciences' (KOD) quarterly Interest & Investment Income came in at $1.6 million in Q1 2026, up 2.43% YoY from $1.6 million in Q1 2025, and up 116.78% on a QoQ basis from $757000.0 in Q4 2025.

Analysis

Kodiak Sciences (KOD) Interest & Investment Income (2018 - 2026) Analysis & Trends

Kodiak Sciences (KOD) has 9 years of Interest & Investment Income data on file, last reported at $1.6 million in Q1 2026.

  • Quarterly Interest & Investment Income rose 2.43% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.6 million (down 51.52% YoY) and the FY2025 annual result came in at $4.5 million, down 59.48% from the prior year.
  • Interest & Investment Income advanced to $1.6 million in Q1 2026, from $757000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $4.7 million in Q2 2023 to a low of $76000.0 in Q1 2022.
  • A 5-year average of $2.4 million and a median of $2.5 million in 2022 frame the typical range for Interest & Investment Income.
  • Annual changes were most pronounced in 2022 — Interest & Investment Income soared 10675.0% — and 2025, when it slumped 66.17%.
  • Tracing KOD's Interest & Investment Income over 5 years: stood at $3.0 million in 2022, then advanced by 29.17% to $3.9 million in 2023, then slumped by 45.34% to $2.1 million in 2024, then plunged by 64.46% to $757000.0 in 2025, then surged by 116.78% to $1.6 million in 2026.
  • The last three Interest & Investment Income figures came in at $1.6 million (Q1 2026), $757000.0 (Q4 2025), and $917000.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 48.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 67.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 35.58 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 27.90 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 28.14 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 5.13 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 10.98 Mn
10 Kodiak Sciences 2.21 Bn 2.21 Bn - 1.26 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.26 Mn
Mar 31, 2026 1.64 Mn
Dec 31, 2025 757,000.00
Sep 30, 2025 917,000.00
Jun 30, 2025 1.24 Mn
Mar 31, 2025 1.60 Mn
Dec 31, 2024 2.13 Mn
Sep 30, 2024 2.71 Mn
Jun 30, 2024 2.95 Mn
Mar 31, 2024 3.35 Mn
Dec 31, 2023 3.90 Mn
Sep 30, 2023 4.54 Mn
Jun 30, 2023 4.68 Mn
Mar 31, 2023 3.62 Mn
Dec 31, 2022 3.02 Mn
Sep 30, 2022 2.48 Mn
Jun 30, 2022 1.49 Mn
Mar 31, 2022 76,000.00
Dec 31, 2021 28,000.00
Sep 30, 2021 40,000.00